Cargando…

Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction

The mechanisms and mediators underlying common renal impairment after myocardial infarction (MI) are still poorly understood. The present study aimed to test the hypothesis that angiotensin II type 1 receptor blockers (ARBs) provides renoprotective effects after MI by preventing augmented intrarenal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Zhu-zhi, Cai, Mu-yan, Mai, Zun, Jin, Dong-mei, Chen, Yang-xin, Huang, Hui, Geng, Deng-feng, Wang, Jing-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682995/ https://www.ncbi.nlm.nih.gov/pubmed/23799145 http://dx.doi.org/10.1371/journal.pone.0067242

Ejemplares similares

The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System
por: Kim, Suyeon, et al.
Publicado: (2006)

Involvement of the Intrarenal Renin-Angiotensin System in Experimental Models of Glomerulonephritis
por: Urushihara, Maki, et al.
Publicado: (2012)

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
por: Kovarik, Johannes J., et al.
Publicado: (2019)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function
por: Matsuyama, Takashi, et al.
Publicado: (2018)

JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation
por: Satou, Ryousuke, et al.
Publicado: (2012)

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease
por: Saigusa, Takamitsu, et al.
Publicado: (2015)

Circulating and intrarenal renin–angiotensin systems in healthy men and nonpregnant women
por: Pringle, Kirsty G, et al.
Publicado: (2015)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease
por: Fuwa, Daisuke, et al.
Publicado: (2016)

Intrarenal renin–angiotensin system activation and macrophage infiltrations in pediatric chronic glomerulonephritis
por: Hattori, Tomoki, et al.
Publicado: (2023)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Characterization of the intrarenal renin‐angiotensin system in cats with naturally occurring chronic kidney disease
por: Lourenço, Bianca N., et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

New Frontiers in the Intrarenal Renin-Angiotensin System: A Critical Review of Classical and New Paradigms
por: Zhuo, Jia L., et al.
Publicado: (2013)

The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors
por: Ohashi, Naro, et al.
Publicado: (2018)

Effect of intrarenal renin-angiotensin-aldosterone system on renal function in patients after cardiac surgery
por: Niu, Peiyuan, et al.
Publicado: (2022)

Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review
por: Bahreini, Elham, et al.
Publicado: (2021)

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin–Angiotensin–Aldosterone System Associated Epithelial-to-Mesenchymal Transition
por: Sun, Chiao-Yin, et al.
Publicado: (2012)

H(2)S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation
por: Xue, Hong, et al.
Publicado: (2013)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020)

Effect of a SGLT2 inhibitor on the systemic and intrarenal renin–angiotensin system in subtotally nephrectomized rats
por: Li, Lei, et al.
Publicado: (2017)

Inhibition of indoxyl sulfate-induced intrarenal renin-angiotensin system activation: targeting the aryl hydrocarbon receptor
por: Akbar, Muhammad Firman
Publicado: (2017)

Activation of the Renin–Angiotensin System Disrupts the Cytoskeletal Architecture of Human Urine-Derived Podocytes
por: Erichsen, Lars, et al.
Publicado: (2022)

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
por: Escobar, Johao, et al.
Publicado: (2023)

Reference genes for mesangial cell and podocyte qPCR gene expression studies under high-glucose and renin-angiotensin-system blocker conditions
por: Hosni, Nicole Dittrich, et al.
Publicado: (2021)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
por: Siragy, Helmy M
Publicado: (2011)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
por: Caminhotto, R de O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ut3jqi5k973q9o8nbk5k7ct9tf